NovaBridge Biosciences

Contributing Author

Recent Articles by NovaBridge Biosciences

6 hours	NovaBridge and Visara Announce Positive Results from VIS-101 Phase 2a Wet AMD Study NBP GlobeNewswire
Mar-03	NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026 NBP -7.25% GlobeNewswire
Mar-02	NovaBridge to Present at the Leerink Partners 2026 Global Healthcare Conference NBP +5.18% GlobeNewswire
Feb-19	NovaBridge Appoints Biotech Leader, Emmett T. Cunningham, Jr, MD, PhD, MPH, as Vice Chairman of the Board to Further Accelerate Global Biotech Platform NBP GlobeNewswire
Feb-17	NovaBridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined with Immunochemotherapy in Patients with 1L Metastatic Gastric Cancer NBP GlobeNewswire
Jan-20	NovaBridge Announces Open Market Purchases by Executive Chairman, Fu Wei NBP +5.09% GlobeNewswire
Jan-06	NovaBridge Presents Positive Givastomig Dose Expansion Data from the Phase 1b Combination Study in Patients with 1L Metastatic Gastric Cancer NBP -11.21% GlobeNewswire
Dec-30	NovaBridge to Ring the Nasdaq Opening Bell on Friday, January 2, 2026 NBP GlobeNewswire
Dec-10	NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO NBP GlobeNewswire
Dec-03	NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO NBP GlobeNewswire
Nov-20	NovaBridge's Visara Subsidiary Appoints Distinguished Ophthalmology Leaders as Chief Medical Officer and Scientific Advisory Board Chair to Drive VIS-101 Forward NBP GlobeNewswire